KAKEN PHARMACEUTIAL CO., LTD.JP:4521Balance sheet

Market cap
¥188.4B
P/E ratio
67.5x
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -10,55329,84533,86745,09546,95659,72263,70661,02559,56150,62554,093
Marketable securities, current -14,21411,8999,8997,59911,59913,59913,59913,59914,69914,69915,992
Accounts receivable, net-28,20429,86828,23133,31530,34021,80020,54920,26019,26823,74421,178
Inventories-7,3237,3998,0047,1786,1134,7625,7005,8076,7348,0628,805
Total current assets-69,01688,99190,494105,055103,731108,336113,662110,613109,903106,974111,377
Property, plant and equipment, net-25,96126,72626,27126,14126,40225,51825,02025,73425,49825,35527,629
Marketable securities, non-current -15,35714,40015,94318,48817,06815,03617,36817,09317,51120,53218,875
Total non-current assets-46,11843,99944,56547,36252,25449,53849,66954,56756,42564,64879,045
Total assets -115,135132,991135,060152,417155,985157,875163,332165,181166,328171,623190,422
Accounts payable-12,29512,2569,85412,20410,7297,7208,4255,8616,1306,9768,186
Short-term debt-4,1953,8753,8753,8753,8753,8503,8503,8503,8503,8503,850
Total current liabilities-30,36933,86124,02031,40127,58021,65521,27619,04920,83819,02430,354
Total non-current liabilities-7,6659,2558,3847,1417,2747,7505,7987,8068,6538,8437,433
Total liabilities -38,03543,11632,40538,54334,85429,40627,07426,85529,49127,86837,787
Common stock and paid-in capital -35,25935,26035,26035,26135,26135,25935,25935,25935,25935,31536,785
Retained earnings-52,93268,60984,33197,284109,057114,869122,462126,347126,135128,506135,242
Stockholders' equity68,09677,10089,875102,655113,874121,131128,468136,257138,325136,836143,755152,634